All relevant data are within the paper.

Introduction {#sec001}
============

American cutaneous leishmaniasis (ACL) is caused by 15 species of the genus *Leishmania* (Kinetoplastida: Trypanosomatidae), which includes species from the *Leishmania* and the *Viannia* subgenera. The latter is also able to cause mucocutaneous (MCL) leishmaniasis. *L*. *(L*.*) amazonensis* is one of the major etiological agents of ACL and it is grouped into the \"*L*. *mexicana* complex\". The initial ACL lesions are crater-shaped and they become ulcerated in the center with the progression of the disease. The species *L*. *mexicana*, *L*. *pifanoi* and *L*. *amazonensis* are also able to cause an infrequent form of the disease termed anergic diffuse cutaneous leishmaniasis (ADCL) \[[@pone.0164344.ref001]\], which is characterized by diffuse nodular lesions and total or partial anergy. ACL and ADCL are not life threatening, as a difference with visceral leishmaniasis (VL) caused by other species, but they are responsible for considerable morbidity.

According to the WHO epidemiological records, about 1.5 millon cases of CL are registered worldwide anually. Most ACL cases are concentrated in Brazil, Bolivia, Colombia and Peru \[[@pone.0164344.ref002], [@pone.0164344.ref003]\]. A recent increase in the cases of leishmaniasis has been observed globally, which may be explained by many interrelated factors as scarce control, poverty, poor hygiene, migrations, return to rural areas, penetration into the jungle, changes in ambient humidity, deforestation, etc. ACL is a zoonosis and the major reservoirs are rodents when the etiological agents belong to the *L*. *mexicana* complex \[[@pone.0164344.ref002]\].

The life cycle of the parasite involves an invertebrate host that injects the motile promastigote stage of the parasite to the mammalian host when feeding from venules of the dermis. The vector belongs to the genus *Lutzomyia* (Psychodidae: Phlebotominae) in the case of New World species of the parasite like *L*. *amazonensis*. Promastigotes are engulfed by host phagocytes and differentiate to amastigotes. When a sand fly feeds from blood of an infected mammal, amastigotes are released from phagocytes, transform into undifferentiated (procyclic) promastigotes and begin a developmental process from the procyclic to the more infective metacyclic stage.

A remarkable number of trypanosomatid genome sequences were assembled and annotated \[[@pone.0164344.ref004]--[@pone.0164344.ref006]\], which allowed for studying differential gene expression in different species, thus contributing to the knowledge about the biology of the parasite \[[@pone.0164344.ref007]\]. This is essential for future discovery of drug targets and vaccine candidates. In the case of *L*. *amazonensis*, two-dimension electrophoresis (2DE) maps of promastigotes were described \[[@pone.0164344.ref008], [@pone.0164344.ref009]\]. In another study, the effect of culture passage and the resulting decrease of infectivity in the proteome profile of stationary phase promastigotes were evaluated by the same approach \[[@pone.0164344.ref010]\]. Also, a transcriptome analysis focused in the search of genes associated to antimony resistance was performed in promastigotes at the mid-logarithmic phase of growth in axenic culture \[[@pone.0164344.ref011]\]. However, differential gene expression throughout growth and development of the promastigote stage of *L*. *amazonensis* in culture and within the sand fly gut has not been still explored. The aim of this study is comparing different time points of growth of promastigotes in culture by 2DE and subsequent matrix-assisted laser desorption-ionization tandem time-of-flight mass spectrometry (MALDI-TOF/TOF).

Materials and Methods {#sec002}
=====================

Parasites {#sec003}
---------

Promastigotes of the *L*. *amazonensis* strain MHOM/Br/79/María were kindly provided by Alfredo Toraño and Mercedes Domínguez \[[@pone.0164344.ref012]\] and cultured at 27°C, pH 7.2 in liquid media composed of RPMI 1640 supplemented with L-glutamine (Life Technologies, Carlsbad, CA), 10% heat inactivated fetal bovine serum (Lonza, Basel, Switzerland) and 100 μg/ml streptomycin-- 100 IU/ml penicillin (Life Technologies). The initial cell density was adjusted to 2 x 10^6^ cells/ml in all cultures and growth was registered daily at the light microscope using a Neubauer chamber. Culture samples containing 10^8^ promastigotes were obtained at the early-logarithmic, mid-logarithmic, late-logarithmic and stationary phases.

Total protein extracts {#sec004}
----------------------

Promastigotes (10^8^ per sample) were harvested at 2,000 g for 10 min and washed once in PBS. Then, the sediment was carefully resuspended in 150 μl lysis buffer (8.4 M urea, 2.4 M thiourea, 5% CHAPS, 50 mM DTT, 1% Triton X-100, 50 μg/ml DNase and Mini EDTA-free Protease Inhibitor Cocktail according to the manufacturer's instructions --Roche, Mannheim, Germany) and immediately mixed by mild rotation at 4°C for 30 min. Then, the protein extracts were centrifuged at 8,000g for 10 min. The supernatant was recovered, precipitated with methanol/chloroform \[[@pone.0164344.ref013]\], dried at room temperature for 5 min and resuspended in 2X rehydration buffer (7 M urea, 2 M thiourea, 4% CHAPS, 0.003% bromophenol blue). Quantification was performed with the RC DC protein assay kit (BioRad) following the manufacturer's instructions and the results were compared with SDS-PAGE results as described \[[@pone.0164344.ref014]\].

Two-dimensional electrophoresis (2DE) {#sec005}
-------------------------------------

Fifty μg of total protein per sample were diluted to a final volume of 140 μl in 2X isoelectrofocusing (IEF) buffer (18.2 M DTT and 0.5% *IPG buffer solution* pH 3--10, BioRad). Then, samples were subject to IEF on 7 cm IPG pH 3--10 non-linear gradient strips (BioRad) in a Protean IEF Cell system (BioRad) following the manufacturer\'s instructions. Each run comprised seven steps (50 V for 12h, 250 V for 1h, 500 V for 1h, 1000 V for 1h, 2000 V for 1h, linear ramp to 8000 V for 1h and 8000 V up to 3500 V·h), reaching more than 12,000 V·h in every one. Then, the strips were run by 12% SDS-PAGE in a pre-cooled MiniProtean 3 Dodeca Cell system (BioRad) at 0.5 W/gel for 30 min and then at 1.5 W. The run was stopped 5 min after the die-front reached the bottom edge. The gels were stained with SYPRO Ruby (BioRad) and the gel images were acquired with EXQuest Spot Cutter (BioRad) according to the manufacturer\'s instructions.

The gel images were processed and analyzed with PDQuest 2D Advanced 8.0.1 software (BioRad) according to the manufacturer\'s instructions. First, the images were cropped and spots were detected automatically with the Spot Detection Parameter Wizard at a sensitivity value of 3.5. Then, all detected spots were manually checked by observation of 3D density graphs, single spot quantitation histograms and 2DE gel images. Normalization was performed by the Total Quantity in Valid Spots algorithm. Normality was checked by the Kolmogorov-Smirnov test and statistical inference of differential protein abundance was performed by the Student\'s t-test at the 0.05 significance level. Reproducibility was assured by preparing three independent biological replicate samples. However, all 2DE runs were performed simultaneously, which is essential for technical reproducibility across gels. For this purpose, all samples were stored at -80°C until use.

Protein identification by MALDI-TOF/TOF {#sec006}
---------------------------------------

After excision of the selected spots with EXQuest Spot Cutter (BioRad), they were digested with trypsin and prepared for MALDI-TOF/TOF mass-spectrometry as described \[[@pone.0164344.ref014]\]. The digests were deposited in OptiTOF^™^ Plates (Life Technologies). Each well contained a 0.8 μl drop of peptides mixed with 0.8 μl of 3 μg/μl α-cyano-4-hydroxycinnamic acid (Sigma). The mixtures were allowed to dry at room temperature and run in an ABI 4800 MALDI-TOF/TOF mass spectrometer (Life Technologies) in positive reflector mode at 25 kV for MS and 1 kV for MS/MS. The data obtained were analyzed with ABI 4000 Series Explorer software 3.6 (Life Technologies). Peptide mass fingerprinting (PMF) and MS/MS spectra of fragment ions were smoothed and corrected to the zero baseline using routines embedded in ABI 4000 Series Explorer Software v3.6. Each PMF spectrum was internally calibrated with the mass signals of trypsin autolysis ions to reach a typical mass measurement accuracy \< 25 ppm. Known trypsin and keratin mass signals, as well as potential sodium and potassium adducts (+21 Da and + 39 Da) were removed from the peak list. Protein identifications were performed with MASCOT 2.1 using Global Protein Server Explorer 4.9 (Life Technologies). The following search parameters were introduced: enzyme, trypsin; allowed missed cleavages, 1; carbamidomethyl cystein as fixed modification by treatment with iodoacetamide; variable modifications, oxidation of methionine; mass tolerance was set to ± 50 ppm for precursors and to ± 0.3 Da for MS/MS fragment ions. The confidence interval for protein identification was set to ≥ 95% (p \< 0.05) and only peptides with an individual ion score above the identity threshold (52) were considered correctly identified. The reference template for MASCOT identifications was the genome sequence of *L*. *mexicana* (<http://tritrypdb.org/common/downloads/release-9.0/LmexicanaMHOMGT2001U1103/fasta/data/>) because the genome of *L*. *amazonensis* has not been sequenced yet and this species is included in the \"*L*. *mexicana* complex\". All data were also run against against individual *L*. *amazonensis* sequences within the NCBInr database. The identifications are available in the PRIDE repository of the ProteomeXchange Consortium \[[@pone.0164344.ref015]\] with the accesion number PXD002939.

Evaluation of resistance to nitric oxide (NO) by the \[3\'-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide\] (MTT) assay {#sec007}
-----------------------------------------------------------------------------------------------------------------------------------

Logarithmic and stationary phase promastigotes were washed with PBS and at 26°C for 4 h at a cell density of 10^6^ in a final volume of 100 μl in the presence of different concentrations (1:2 serial dilutions from 16 to 0.25 mM) of NaNO~2~ (NO donor) in PBS pH 5.0. Next, suspensions were centrifuged at 700g for 10 min and the sediments were resuspended in 100 μl PBS pH 7.0. Then, 10 μl of 5 mg/ml MTT were added and the cells were incubated at 25°C for 4 h. The reaction was stopped and formazan solubilized by adding 100 μl of 0.4N HCl in 50% isopropanol. Finally, A~490nm~ was measured to assess formazan accumulation, which is related to viability \[[@pone.0164344.ref016]\]. The differences were statistically assessed with the paired Student's t-test from three biological replicates of the experiment.

Results and Discussion {#sec008}
======================

2DE-MS/MS analysis of *L*. *amazonensis* promastigotes {#sec009}
------------------------------------------------------

Total protein was extracted from *L*. *amazonensis* axenic cultures of promastigotes at early-logarithmic (day 2), mid-logarithmic (day 3), late-logarithmic (day 5) and stationary (day 7) phase ([Fig 1](#pone.0164344.g001){ref-type="fig"}). Average protein concentrations (mg/ml) were: 4.4 ± 0.2 (day 2 promastigotes); 4.5 ± 0.4 (day 3); 4.4 ± 0.1 (day 5); 4.5 ± 0.2 (day 7). ([Fig 2](#pone.0164344.g002){ref-type="fig"}). The spots were automatically detected with the Spot Detection Parameter Wizard. Sensitivity was adjusted to 3.5 in order to filter out the non-identifiable faintest spots according to experimental setup with the mass spectrometer. An average of 202 spots were detected per gel and the cumulative non-redundant number is 339 ([S1 Table](#pone.0164344.s002){ref-type="supplementary-material"}). The cut-off ratio values were 1.7 for up-regulation and 0.6 for down-regulation (1.7 and -1.7 fold changes), respectively ([S1 Fig](#pone.0164344.s001){ref-type="supplementary-material"}, [S1 Table](#pone.0164344.s002){ref-type="supplementary-material"}). Statistical significance was inferred with the Student's t test (p \< 0.05) because the outcome of the Kolmogorov-Smirnov test was p = 0.318, 0.280 and 0.273 for the comparisons day3:day2, day5:day2 and day7:day2, respectively. Ratios are relative to early-logarithmic phase promastigotes (day 2). Sixty three differentially expressed proteins out of 339 could be identified by MALDI-TOF/TOF ([Fig 2](#pone.0164344.g002){ref-type="fig"}, [Table 1](#pone.0164344.t001){ref-type="table"}, [S1 Table](#pone.0164344.s002){ref-type="supplementary-material"}) against the TriTrypDB *L*. *mexicana* genome annotations. All selected proteins were identified and the MASCOT score values were significant, except for one spot that could not be identified with the *L*. *mexicana* reference genome sequence but the NCBInr database instead ([Table 2](#pone.0164344.t002){ref-type="table"}, spot Lam1601, soluble promastigote surface antigen fragment PSA-31S, part of the PSA-38S). In fact, this *L*. *amazonensis* gene had been previously characterized \[[@pone.0164344.ref017]\]. Random identification of constitutively expressed proteins was also performed ([Table 2](#pone.0164344.t002){ref-type="table"}), which occasionally allowed for retrieving additional information about relative expression in different pathways (see below). In certain cases, different spots contain the same protein, which may be due to protein processing, post-translational modifications or protein aggregation. In the next sections, this has been cited as \"protein variant\". In principle, the nature of the variations is unknown but the 2DE-resolved variants could be separately analyzed and identified. The comparison of experimental and/or predicted molecular weight and isoelectric point provides insight ([Table 3](#pone.0164344.t003){ref-type="table"}). For example, three variants of the protein LmxM.15.1160 were found. Two of them present a similar MW but differ in the estimated pI value in 0.5 pH units, whereas the MW of the third one is about 40% lower and the pI 8.5, which strongly suggests that a considerable portion of the protein sequence has been removed during intracellular protein processing. The most striking changes in experimental MW and pI ([Table 3](#pone.0164344.t003){ref-type="table"}) are discussed below according to changes in relative abundance of variants of the same protein.

![Growth curve of *L*. *amazonensis* promastigotes.\
Total protein samples were prepared and quantified at day 2 (early logarithmic phase), day 3 (mid logarithmic phase), day 5 (late logarithmic phase/early stationary phase) and day 7 (stationary phase).](pone.0164344.g001){#pone.0164344.g001}

![Examples of 2DE of total protein extracts of *L*. *amazonensis* promastigotes.\
(A) Early logarithmic (day 2) and (B) stationary phase (day 7). IEF was performed in a non-linear 3--10 pH interval. (C) 3D density graphs of spots Lam2801, Lam3501, Lam6102 and Lam7004 obtained with PD Quest software.](pone.0164344.g002){#pone.0164344.g002}

10.1371/journal.pone.0164344.t001

###### Differential gene expression regulation in *L*. *amazonensis* promastigotes.

The MW and pI values provided were estimated by the 2DE analysis software PD Quest. Theoretical values can be obtained from the *L*. *mexicana* LmxM genome databank within TriTrypDB by introducing the gene Ids. provided in this table.

![](pone.0164344.t001){#pone.0164344.t001g}

  Spot      TriTrypDB ID           Protein                                                                                              MASCOT score (p \< 0.05)   MW (KDa)   pI    Day3:Day2 (p \< 0.05)   Day5:Day2 (p \< 0.05)   Day7:Day2 (p \< 0.05)
  --------- ---------------------- ---------------------------------------------------------------------------------------------------- -------------------------- ---------- ----- ----------------------- ----------------------- -----------------------
  Lam 102   LmxM.34.4470           Hypothetical protein, conserved                                                                      300                        23.74      3.3   0.51 (-1.96)            0.39 (-2.56)            0.56 (-1.78)
  Lam1101   LmxM.04.0770/ 60       Unspecified product                                                                                  96/89                      23.16      4.0                           0.5 (-2.00)             0.31 (-3.22)
  Lam1103   LmxM.14.0190           Hypothetical protein, conserved                                                                      512                        25.18      4.7   0.57 (-1.75)                                    
  Lam1204   LmxM.36.3210           14-3-3 protein 1, putative                                                                           442                        27.66      4.6                           0.36 (-2.78)            
  Lam1205   LmxM.08.1230           Beta tubulin                                                                                         640                        30.55      4.8                                                   2.55
  Lam1503   LmxM.25.0750           Protein phosphatase, putative                                                                        512                        44.71      4.6   0.53 (-1.89)                                    0.56 (-1.78)
  Lam1702   LmxM.13.0160           Protein kinase A regulatory subunit, putative                                                        70                         66.63      4.7                                                   24.28
  Lam2001   LmxM.15.0281/75        Ribonucleoprotein p18, mitochondrial precursor, putative                                             247/247                    17.44      5.2                           0.34 (-2.94)            
  Lam2202   LmxM.13.0300           Unspecified product                                                                                  206                        27.99      5.1                                                   40.22
  Lam2304   LmxM.14.0310           Proteasome alpha 3 subunit                                                                           187                        31.14      5.3                                                   1.86
  Lam2401   LmxM.25.1710           Pyruvate dehydrogenase E1 beta subunit, putative                                                     133                        38.28      5.2   0.27 (-3.7)             0.17 (-5.89)            
  Lam2801   LmxM.32.0312/ 14/16    Heat shock protein 83--1                                                                             614/614/614                91.86      5.0   3.03                                            
  Lam3102   LmxM.23.0040           Peroxidoxin                                                                                          589                        22.38      5.5                           0.36 (-2.78)            
  Lam3201   LmxM.34.1480           Arginase (ARG)                                                                                       67                         27.65      5.5                           18.08                   28.89
  Lam3301   LmxM.34.1540           Rieske iron-sulfur protein, mitochondrial precursor, putative (RISP)                                 105                        32.87      5.5                           0.38 (-2.63)            
  Lam3501   LmxM.28.2770/80        Heat-shock protein hsp70, putative                                                                   234/165                    44.50      5.4                                                   24.06
  Lam3505   LmxM.07.0640           Hypothetical protein, conserved                                                                      320                        40.57      5.5                           0.09 (-11.1)            
  Lam3601   LmxM.14.1160           Enolase                                                                                              586                        49.17      5.6                           0.48 (-2.08)            0.49 (-2.04)
  Lam3701   LmxM.36.2020/30        Chaperonin hsp60, mitochondrial precursor                                                            820/356                    67.83      5.3                           0.01 (-100)             
  Lam3704   LmxM.36.2030/20        Chaperonin hsp60 mitochondrial precursor                                                             700                        66.34      5.5                           0.21 (-4.76)            0.49 (-2.04)
  Lam3705   LmxM.36.6650           2,3-bisphosphoglycerate-independent phosphoglycerate mutase                                          304                        68.99      5.5                           60.01                   
  Lam3801   LmxM.28.2770/80        Heat-shock protein hsp70, putative                                                                   990/211                    73.81      5.4                           0.44 (-2.27)            
  Lam3803   LmxM.29.2490/60/70     Heat shock 70-related protein 1, mitochondrial precursor, putative                                   874/727/726                76.87      5.5                           0.32 (-3.12)            
  Lam3901   LmxM.22.1540           Alanyl-tRNA synthetase, putative                                                                     376                        112.48     5.6   1.83                                            
  Lam4001   LmxM.23.0200           Endoribonuclease L-PSP (pb5), putative                                                               360                        12.93      5.7                                                   1.76
  Lam4002   LmxM.34.1300           Ubiquitin-conjugating enzyme E2, putative                                                            135                        12.16      5.5                           0.46 (-2.17)            
  Lam4401   LmxM.23.0110           Mannose-1-phosphate guanyltransferase (GDP-MP)                                                       344                        39.32      5.6                           2.63                    
  Lam4403   LmxM.30.2250           3,2-trans-enoyl-CoA isomerase, mitochondrial precursor, putative                                     251                        37.59      5.7   0.59 (-1.70)                                    
  Lam5001   LmxM.15.1160/40        Tryparedoxin peroxidase                                                                              200/75                     12.88      5.9                                                   30.53
  Lam5002   LmxM.20.1280           Calpain-like cysteine peptidase, Clan CA, family C2, putative                                        324                        13.92      6.1                           0.02 (-50.00)           0.01 (-100.00)
  Lam5103   LmxM.15.1160/40        Tryparedoxin peroxidase                                                                              216/82                     21.97      6.0   47.02                                           
  Lam5302   LmxM.28.2740           Activated protein kinase C receptor (LACK)                                                           510                        32.08      6.1   0.51 (-1.96)            0.27 (-3.70)            0.25 (-4)
  Lam5501   LmxM.06.0370           Glutamine synthetase, putative                                                                       262                        41.01      5.9                           0.38 (-2.63)            0.54 (-1.85)
  Lam5502   LmxM.32.2300           UDP-glucose-4\'-epimerase, putative                                                                  354                        43.91      5.9                           0.55 (-1.82)            
  Lam5504   LmxM.06.0880           Acyl-coenzyme A dehydrogenase, putative                                                              146                        44.02      6.1                                                   14.91
  Lam5801   LmxM.30.0010           5-methyltetrahydropteroyltriglutamate-homocysteine methyltransferase, putative (MET6)                575                        92.78      5.9   3.49                                            
  Lam5804   LmxM.36.0180           Elongation factor 2                                                                                  560                        107.45     6.1   1.76                    0.42 (-2.38)            0.41 (-2.43)
  Lam5901   LmxM.36.0180           Elongation factor 2                                                                                  449                        107.63     6.0   2.35                                            
  Lam6102   LmxM.15.1160/40        Tryparedoxin peroxidase                                                                              305/163                    21.94      6.5   0.58 (-1.72)                                    
  Lam6403   LmxM.36.4170           Oxidoreductase, putative                                                                             194                        36.13      6.3                           0.03 (-33.3)            
  Lam6701   LmxM.34.3860           T-complex protein 1, eta subunit, putative                                                           402                        69.50      6.2                           0.06(-16.67)            
  Lam6702   LmxM.36.2660           Dihydrolipoamide acetyltransferase                                                                   128                        55.74      6.3                           0.45 (-2.22)            
  Lam6703   LmxM.11.0630/20        Aminopeptidase, putative,metallo-peptidase, Clan MF, Family M17/aminopeptidase, putative             325/186                    61.94      6.3   3.33                                            2.72
  Lam6704   LmxM.31.3310           Dihydrolipoamide dehydrogenase                                                                       565                        55.19      6.4                                                   0.57 (-1.75)
  Lam6801   LmxM.28.2770           Heat-shock protein hsp70, putative                                                                   190                        73.71      6.2                           0.31 (-3.22)            
  Lam6806   LmxM.31.2951/50        Nucleoside diphosphate kinase b                                                                      553/553                    88.79      6.8   0.09 (-11.1)                                    0.06 (-16.67)
  Lam7003   LmxM.31.2951/50        Nucleoside diphosphate kinase b                                                                      544/544                    13.19      7.5                           0.31 (-3.22)            
  Lam7004   LmxM.31.1820/30        Iron superoxide dismutase, putative                                                                  476/265                    19.91      7.6   1.75                                            
  Lam7603   LmxM.34.1380           Mitochondrial processing peptidase, beta subunit, putative, metallo-peptidase, Clan ME, family M16   522                        52.84      7.0   40.36                                           
  Lam7605   LmxM.34.1380           Mitochondrial processing peptidase, beta subunit, putative, metallo-peptidase, Clan ME, family M16   681                        50.37      7.5   1.76                                            
  Lam7701   LmxM.34.3860           T-complex protein 1, eta subunit, putative                                                           427                        63.99      6.8                           0.4 (-2.5)              0.52 (-1.92)
  Lam7702   LmxM.36.0180           Elongation factor 2                                                                                  300                        60.30      6.9   3.34                                            
  Lam7703   LmxM.36.0070           Stress-inducible protein STI1 homolog                                                                318                        65.49      7.4   0.5 (-2.00)             0.24 (-4.17)            0.59 (-1.70)
  Lam7801   LmxM.18.0510           Aconitase, putative                                                                                  502                        103.24     7.0                           0.43 (-2.32)            
  Lam8003   LmxM.06.0120           Cyclophilin                                                                                          321                        13.18      9.2   0.51 (-1.96)            0.48 (-2.08)            
  Lam8005   LmxM.26.1380           Prefoldin-like protein/Cyclophilin, putative                                                         125/106                    21.02      9.5   30.56                                           
  Lam8101   LmxM.24.0850           Triose phosphate isomerase                                                                           621                        23.26      9.1   0.44 (-2.27)            0.43 (-2.32)            
  Lam8102   LmxM.36.0070           Stress-inducible protein STI1 homolog                                                                347                        25.49      9.4                           0.43 (-2.32)            
  Lam8201   LmxM.24.1980           Hypothetical protein, conserved                                                                      404                        30.12      9.2                                                   15.15
  Lam8501   LmxM.31.0840           Hypothetical protein, conserved                                                                      188                        42.92      8.2                           0.36 (-2.78)            0.33 (-3.03)
  Lam8701   LmxM.25.1120           Aldehyde dehydrogenase, mitochondrial precursor                                                      497                        54.99      8.0                                                   1.77
  Lam8703   LmxM.07.0340           ATP-dependent DEAD/H RNA helicase, putative                                                          201                        67.09      9.4   6.04                                            
  Lam8706   LmxM.03.0200/24.0770   Delta1-pyrroline-5-carboxylate dehydrogenase, putative/Malic enzyme, putative                        181/163                    59.28      9.1   20.4                                            

10.1371/journal.pone.0164344.t002

###### Constitutively expressed proteins in *L*. *amazonensis* promastigotes.

The MW and pI values provided were estimated by the 2DE analysis software PD Quest. Theoretical values can be obtained from the *L*. *mexicana* LmxM genome databank within TriTrypDB by introducing the gene Ids. provided in this table.

![](pone.0164344.t002){#pone.0164344.t002g}

  Spot      TriTrypDB ID          Protein                                                                                             MASCOT score (p \< 0.05)   MW (KDa)   pI
  --------- --------------------- --------------------------------------------------------------------------------------------------- -------------------------- ---------- -----
  Lam1601   ACY70938 (NCBI Id.)   Soluble promastigote surface antigen PSA-31S                                                        221                        74.38      4.4
  Lam2502   LmxM.32.0312/14/16    Heat shock protein 83--1                                                                            288/288/288                61.34      5.1
  Lam2601   LmxM.36.6940          Protein disulfide isomerase                                                                         395                        73.85      5.5
  Lam2803   LmxM.28.1200          Glucose-regulated protein 78, putative                                                              611                        105.47     5.2
  Lam2804   LmxM.36.1370          Transitional endoplasmic reticulum ATPase, putative, valosin-containing protein homolog             185                        147.73     5.7
  Lam3001   LmxM.08_29.1160       Tryparedoxin 1, putative (TXN1)                                                                     228                        13.20      5.4
  Lam3802   LmxM.29.1760/50       Paraflagellar rod protein 1D, putative                                                              312/312                    127.12     5.4
  Lam4601   LmxM.32.2540          Carboxypeptidase, putative,metallo-peptidase, Clan MA(E), Family M32                                457                        79.14      5.7
  Lam4801   LmxM.26.1570          Thimet oligopeptidase, putative,metallo-peptidase, Clan MA(E), Family M3                            247                        98.15      5.7
  Lam4803   LmxM.28.2770/20       Heat-shock protein HSP70, putative                                                                  199                        97.64      5.8
  Lam5503   LmxM.01.0770          Unspecified product                                                                                 315                        73.92      6.0
  Lam5506   LmxM.36.2950          Succinyl-CoA ligase (GDP-forming) beta chain, putative                                              748                        54.02      6.2
  Lam5702   LmxM.27.1260          T-complex protein 1, beta subunit, putative                                                         279                        80.04      6.1
  Lam5803   LmxM.36.0180          Elongation factor 2                                                                                 136                        124.23     6.0
  Lam6402   LmxM.25.1610          Hypothetical protein, conserved                                                                     79                         62.25      6.4
  Lam6705   LmxM.27.1220          Hypothetical protein, conserved                                                                     145                        78.46      6.6
  Lam7503   LmxM.10.0290          Isocitrate dehydrogenase (NADP), mitochondrial precursor, putative                                  283                        65.21      7.5
  Lam7602   LmxM.18.0670          Citrate synthase, putative                                                                          273/270                    74.91      6.8
  Lam7604   LmxM.21.0340          Mitochondrial processing peptidase alpha subunit, putative,metallo-peptidase, Clan ME, Family M16   223                        74.26      7.2
  Lam8001   LmxM.15.1160/40       Tryparedoxin peroxidase                                                                             248/102                    22.46      8.5
  Lam8103   LmxM.21.0850          Xanthine phosphoribosyltransferase                                                                  319                        24.12      9.4
  Lam8203   LmxM.36.5120/10       40S ribosomal protein SA, putative                                                                  354/255                    34.03      9.4
  Lam8403   LmxM.36.1260          Fructose-1,6-bisphosphate aldolase                                                                  458                        66.15      9.5
  Lam8601   LmxM.32.2340          Succinyl-CoA:3-ketoacid coenzyme A transferase, mitochondrial precursor, putative                   712                        68.41      8.2
  Lam9201   LmxM.02.0460          Voltage-dependent anion-selective channel, putative (VDAC)                                          298                        36.34      9.5
  Lam9301   LmxM.25.2130/40       Succinyl-CoA synthetase alpha subunit, putative                                                     319/319                    47.70      9.5
  Lam9401   LmxM.29.2980          Glyceraldehyde-3-phosphate dehydrogenase, glycosomal                                                458                        48.53      9.5

10.1371/journal.pone.0164344.t003

###### Remarkable examples of protein variants.

Comparison of experimental (Exp) and predicted theoretical (P) MW and pI.

![](pone.0164344.t003){#pone.0164344.t003g}

  TriTryp Id.    Protein         ^Exp^MW   ^P^MW   ^Exp^pI   ^P^pI
  -------------- --------------- --------- ------- --------- -------
  LmxM.15.1160   TryP            12.9      22.2    8.5       6.7
  LmxM.15.1160   TryP            22.0      22.2    6.0       6.7
  LmxM.15.1160   TryP            21.9      22.2    6.5       6.7
  LmxM.28.2770   HSP70           44.5      71.2    5.4       5.2
  LmxM.28.2770   HSP70           73.8      71.2    5.4       5.2
  LmxM.28.2770   HSP70           73.7      71.2    6.2       5.2
  LmxM.28.2770   HSP70           97.6      71.2    5.8       5.2
  LmxM.29.2490   HSP70-rel1      76.9      72.5    5.5       5.7
  LmxM.31.2951   NDKb            88.79     16.7    6.8       7.5
  LmxM.31.2951   NDKb            13.2      16.7    7.5       7.5
  LmxM.34.1380   M16 peptidase   52.8      54.6    7.0       7.1
  LmxM.34.1380   M16 peptidase   50.4      54.6    7.5       7.1
  LmxM.36.0180   EF2             107.4     94.1    6.1       6.0
  LmxM.36.0180   EF2             107.6     94.1    6.0       6.0
  LmxM.36.0180   EF2             60.3      94.1    6.9       6.0

The differential gene expression results at the protein abundance level in the promastigote differentiation process studied herein are compared below with expression profiles reported in other species. Experimental variation between studies has been considered. In other cases, the information is complemented with reported data about the differentiation process of promastigotes to amastigotes.

Differential protein abundance in *L*. *amazonensis* promastigotes {#sec010}
------------------------------------------------------------------

### Regulation of gene expression {#sec011}

Proteins involved in translation and post-transcriptional regulation of gene expression, play a key role in the biology of trypanosomatids because these organisms lack most transcriptional regulation mechanisms (reviewed in \[[@pone.0164344.ref018]\]). The abundance of some of them changes in the growth and differentiation process of *L*. *amazonensis* promastigotes. First, three variants of the translation elongation factor 2 (EF2) are up-regulated in mid-logarithmic with respect to early-logarithmic phase promastigotes, as well as two different DEAD/DEAH RNA helicases and the alanine-tRNA synthetase ([Table 1](#pone.0164344.t001){ref-type="table"}). One EF2 variant is considerably lighter and slightly more basic (60.3 KDa, pI 6.9) than the others ([Table 3](#pone.0164344.t003){ref-type="table"}), which suggests that it is partially proteolyzed during processing. The two other variants may have been post-translationally modified, according to the differences in the theoretical MW values (Tables [1](#pone.0164344.t001){ref-type="table"} and [3](#pone.0164344.t003){ref-type="table"}). A heavier variant of the EF2 is constitutively expressed (Tables [2](#pone.0164344.t002){ref-type="table"} and [3](#pone.0164344.t003){ref-type="table"}). This constitutive variant may contain additional post-translational modifications, probably glycosylation regarding to the increase in MW ([Table 3](#pone.0164344.t003){ref-type="table"}). The increase in abundance of the EF2 variants (Tables [1](#pone.0164344.t001){ref-type="table"} and [2](#pone.0164344.t002){ref-type="table"}) suggests changes in translational regulation at an intermediate point of growth and differentiation. The EF2 was described to be an immunostimulatory protein in *L*. *donovani* \[[@pone.0164344.ref019]\], but the importance of this protein for differentiating promastigotes may rely more directly in regulation of translation rather than preparation in advance for colonization of the host cell within the mammalian host (see pre-adaptative hypothesis below). An alternative possibility could be the decrease of the steady-state levels in case the immune response elicited by the protein leads to progression of the disease.

Another protein involved in gene expression regulation is the endoribonuclease L-PSP (pb5), which was found to be down-regulated in amastigotes of species causative of cutaneous (*L*. *mexicana*, *L*. *major*) and visceral (*L*. *donovani*, *L*. *infantum*) leishmaniasis \[[@pone.0164344.ref020]--[@pone.0164344.ref024]\]. However, information about differential abundance of this protein throughout the promastigote growth and differentiation process is not available so far. In the case of *L*. *amazonensis*, this endoribonuclease is over-expressed in stationary phase promastigotes, therefore at the end of the differentiation process ([Table 1](#pone.0164344.t001){ref-type="table"}).

### Protein folding {#sec012}

The heat shock proteins HSP70 and HSP83-1 were described to be abundant and constitutive throughout the main stages of the life cycle of *Leishmania* spp. \[[@pone.0164344.ref025], [@pone.0164344.ref026]\]. Differential expression in the promastigote stage of *L*. *infantum* was not detected at the transcript and protein levels \[[@pone.0164344.ref014], [@pone.0164344.ref020]\]. In the case of *L*. *amazonensis*, distinct variants of both chaperones are constitutively or differentially expressed in promastigotes throughout growth and differentiation (Tables [1](#pone.0164344.t001){ref-type="table"} and [2](#pone.0164344.t002){ref-type="table"}). Two HSP70 (LmxM.28.2770) variants of the same MW but different estimated pI (5.4 and 6.2) are less abundant at late-logarithmic phase (Tables [1](#pone.0164344.t001){ref-type="table"} and [3](#pone.0164344.t003){ref-type="table"}). The HSP70-related protein 1 (HSP70-rel1), encoded by a different gene (LmxM29.2490), is slightly heavier ([Table 3](#pone.0164344.t003){ref-type="table"}) and its relative abundance is analogous, whereas a lighter variant of the LmxM.28.2770 HSP70 (44.5 KDa) of estimated pI around the theoretical value (5.2) is highly up-regulated (24-fold) in stationary phase promastigotes (Tables [1](#pone.0164344.t001){ref-type="table"} and [3](#pone.0164344.t003){ref-type="table"}). Finally, a heavier variant (97.6 KDa) is constitutive (Tables [2](#pone.0164344.t002){ref-type="table"} and [3](#pone.0164344.t003){ref-type="table"}). Therefore, alternation of HSP70 variants originated by protein processing or post-translational modifications is observed at the last stages of the growth and differentiation process of *L*. *amazonensis* promastigotes. Simultaneously, the chaperonin HSP60 is down-regulated (late-logarithmic phase), whereas the differentially regulated variants of the HSP83 are down-regulated at mid-logarithmic phase, an earlier point of growth and differentiation. According to our results, the overall HSP70 levels increase in the ongoing of differentiation of promastigotes considering all variants together. As HSP70 proteins of *L*. *infantum* and *L*. *donovani* were described to be immunostimulatory \[[@pone.0164344.ref019], [@pone.0164344.ref027]\], they may be involved in colonization of the mammalian host phagocytesby differentiated promastigotes, though it may lead to susceptibility or resistance of the host depending on the type of immune response elicited.

According to previous data, the stress-inducible protein 1 homolog (STI1) is constitutively expressed in the developmental process of stationary phase promastigotes to amastigotes in the case of *L*. *infantum* \[[@pone.0164344.ref028]\] but no information is available about growth and development of promastigotes. In the case of *L*. *amazonensis*, the STI1 is down-regulated at late logarithmic phase ([Table 1](#pone.0164344.t001){ref-type="table"}), simultaneously to some HSPs mentioned above.

Two variants of the η subunit of the T-complex protein 1 (TCP1η) are down-regulated in late logarithmic phase promastigotes ([Table 1](#pone.0164344.t001){ref-type="table"}), whereas the TCP1β subunit is constitutively expressed ([Table 2](#pone.0164344.t002){ref-type="table"}). Therefore, the down-regulation of the TCP1η, the STI1 and the HSPs mentioned above is simultaneous and takes place at one of the final stages of growth and differentiation of *L*. *amazonensis* promastigotes in culture. The exact function of the TCP complex is not known in *Leishmania* spp., although it has been suggested that the TCP1γ subunit may participate in maintaining the structural dynamics of the cytoskeleton \[[@pone.0164344.ref029]\]. Changes in cell morphology throughout promastigote differentiation and flagellar movement demand continuous re-organization of the cytoskeleton. Differential expression of the TCP1η has not been reported in *L*. *infantum* promastigotes differentiating in culture so far, although the encoding gene is up-regulated at the transcript level in metacyclic promastigotes isolated from the sand fly anterior midgut \[[@pone.0164344.ref030]\].

A cyclophilin variant is down-regulated in mid-logarithmic phase *L*. *amazonensis* promastigotes, whereas another variant is constitutively expressed. Cyclophilins are able to prevent aggregation of adenosine kinase domain-containing proteins \[[@pone.0164344.ref031], [@pone.0164344.ref032]\] like nucleoside diphosphate kinases (NDK). Two NDKb variants encoded by the same gene but very different in MW (presumably due to processing) are up-regulated at the beginning of growth and differentiation of promastigotes (early-logarithmic phase) (Tables [1](#pone.0164344.t001){ref-type="table"} and [3](#pone.0164344.t003){ref-type="table"}). Up-regulation of the NDKb at the transcript level in procyclic *L*. *infantum* promastigotes \[[@pone.0164344.ref033]\] agrees with the profile found in *L*. *amazonensis*. The NDKs are involved in nucleotide biosynthetic processes, which may occur preferentially at the initial stages of growth and differentiation of promastigotes as suggested by the results. The 14-3-3 protein 1 relative abundance profile is the same as for the NDKb in *L*. *amazonensis* promastigotes. The exact functions of 14-3-3 proteins are unknown, although they have been related to many cellular processes. An intrinsic NDK activity has been associated to these proteins in general \[[@pone.0164344.ref034]\] and antiapoptotic properties of the *L*. *donovani* orthologs have been reported \[[@pone.0164344.ref035]\]. In fact, the 14-3-3 protein is able to prolong the lifespan of the infected host phagocyte. However, given the multiple functions of this protein, the implications of its increased levels at the beginning of promastigote growth and differentiation are not known so far. The decrease of Cph may cause an increase in aggregation of NDKb and 14-3-3, which may be a clue to explain their decrease at an earlier stage.

### Proteolysis {#sec013}

Two components of the ubiquitin-proteasome system are differentially abundant throughout growth and differentiation of *L*. *amazonensis* promastigotes: the ubiquitin-conjugating enzyme E2 (UbqC-E2) is down-regulated in late-logarithmic phase, whereas the proteasome α-3 subunit is up-regulated in stationary phase promastigotes ([Table 1](#pone.0164344.t001){ref-type="table"}). None of them have been detected in differential gene expression analysis during development of promastigotes of any *Leishmania* species in culture so far. However, it has been described that the the E2 steady-state transcript levels are higher in cultured promastigotes than in promastigotes obtained from the sand fly gut \[[@pone.0164344.ref030], [@pone.0164344.ref036]\]. The 14-3-3 protein is associated to other components of the proteasome \[[@pone.0164344.ref037]\]. As mentioned above, the abundance of this protein decreases at the last stages of growth and development of *L*. *amazonensis* promastigotes (late-logarithmic phase promastigotes), which is simultaneous to the decrease of the UbqC-E2.

Other proteases of unknown function are up-regulated in mid-logarithmic phase of growth and development of *L*. *amazonensis* promastigotes: two mitochondrial protein peptidase variants, a metal-dependent aminoexopeptidase of the M17 family and two variants of a mitochondrial processing peptidase of the M16 family that present similar MW and pI analogous to the theoretical value ([Table 3](#pone.0164344.t003){ref-type="table"}). Last, the calpain LmxM.20.1280 is down-regulated in late-logarithmic phase promastigotes, whereas the paralog (LinJ.20.1230) was found to be up-regulated in *L*. *infantum* metacyclic promastigotes \[[@pone.0164344.ref033]\]. The physiological meaning of all these changes in proteasome components and proteases of unknown function is not known so far, although those changes at a mid time point of promastigote differentiaton suggest that they are involved in degradation of self proteins during this process.

### Signaling {#sec014}

The protein kinase A (PKA) of *L*. *amazonensis* was described to be involved in autophagy \[[@pone.0164344.ref038], [@pone.0164344.ref039]\], which is a critical process in promastigote differentiation. This is in agreement with 24-fold increase of the regulatory subunit (rPKA) in stationary phase promastigotes of this species ([Table 1](#pone.0164344.t001){ref-type="table"}). The rPKA is also up-regulated at the transcript level at the same growth phase of *L*. *infantum* promastigotes \[[@pone.0164344.ref020]\]. Therefore, these data point to an increase of abundance of the rPKA upon growth and differentiation of the promastigote stage, which may be critical for survival.

The receptor of the activated protein kinase C (RACK) of *Leishmania* spp. (LACK) is up-regulated in early-logarithmic phase promastigotes in *L*. *amazonensis* ([Table 1](#pone.0164344.t001){ref-type="table"}). Constitutive expression throughout growth of *L*. *infantum* promastigotes has been reported \[[@pone.0164344.ref040]\]. The motile stage of *Crithidia fasciculata*, a monogenetic trypanosomatid that does not infect mammals in its life cycle, also increases the levels of the RACK orthologue CACK in early logarithmic phase \[[@pone.0164344.ref041]\] like *L*. *amazonensis*, according to 2DE-MALDI-TOF/TOF results obtained by the same procedure. The LACK antigen is able to protect partially against canine leishmaniasis when the encoding gene is administered in a mammalian expression plasmid vector either containing antibiotic resistance genes or alternative selection markers \[[@pone.0164344.ref042]\]. This protein is located in the particulate fraction of the cytoplasm near the plasma membrane and it is up-regulated in *L*. *infantum* amastigotes \[[@pone.0164344.ref040]\]. RACK proteins belong to the WD40 repeat family. In particular, LACK is able to bind sequences present in certain proteins involved in DNA replication and RNA synthesis and the β chain of the MHC-II. RACKs are able to translocate PKCs to the required intracellular locations \[[@pone.0164344.ref024]\] in order to participate in certain signal transduction pathways that have been characterized in mammalian cells \[[@pone.0164344.ref025]\]. The current knowledge on signal transduction pathways is still reduced in trypanosomatids. However, progress has been made with particular proteins. For example, at least one of the rPKA functions could be determined (autophagy, involved in metacyclogenesis) and it is known that LACK is a good vaccine candidate \[[@pone.0164344.ref042]\]. The signaling proteins 14-3-3 and putative protein phosphatase in [Table 1](#pone.0164344.t001){ref-type="table"} are more abundant in early logarithmic phase. The 14-3-3 protein is also involved in protein folding. As mentioned above, antiapoptotic function able to prolong the lifespan of the infected macrophage has been also described \[[@pone.0164344.ref035]\].

### Catabolism and biosynthesis of surface molecules {#sec015}

Glycolysis is less active in amastigotes than in promastigotes \[[@pone.0164344.ref043]\]. The opposite has been observed for β-oxidation of fatty acids. Most glycolytic enzymes are compartmentalized in the glycosome and some of them have been considered as potential drug targets \[[@pone.0164344.ref044]--[@pone.0164344.ref046]\]. Thiol groups of glycolytic enzymes are modified under nitrosative stress in *Escherichia coli* and *Mycobacterium tuberculosis*, leading to an appropriate conformational state of the protein that somehow allows for resistance \[[@pone.0164344.ref047], [@pone.0164344.ref048]\]. These findings suggest an interesting hypothetical association between steady-state levels of glycolytic enzymes in the appropriate conformational state and resistance to NO. *M*. *tuberculosis* and certain invasive *E*. *coli* strains are facultative intracellular pathogens, whereas the amastigote of *Leishmania* spp. is an obligate intracellular stage. Promastigotes are also able to survive in the presence of NO. On these grounds, we propose a hypothetical association between differential abundance of glycolytic enzymes and resistance to nitric oxide (see discussion about nitric oxide resistance below). However, this has not been experimentally tested. The triose phosphate isomerase (TPI), the enolase and the bisphosphoglycerate-independent phosphoglycerate mutase (PGM^BPI^) are differentially regulated in *L*. *amazonensis* promastigotes ([Table 1](#pone.0164344.t001){ref-type="table"}), whereas the glyceraldehyde-3-phosphate dehydrogenase (gGAPDH) is constitutively expressed ([Table 2](#pone.0164344.t002){ref-type="table"}). Constitutive expression of the gGAPDH was also described in the differentiation process of *L*. *infantum* promastigotes to amastigotes \[[@pone.0164344.ref028]\]. The abundance of the TPI, a potential vaccine candidate \[[@pone.0164344.ref049]\], decreases in mid-logarithmic phase promastigotes, whereas the PGM^BPI^ is up-regulated at late-logarithmic phase. The PGM^BPI^ was reported to be down-regulated in *L*. *infantum* and *L*. *donovani* amastigotes \[[@pone.0164344.ref020], [@pone.0164344.ref023], [@pone.0164344.ref024], [@pone.0164344.ref050]\] at the transcript and protein levels, respectively. Additionally, this protein is considered a promising drug target candidate \[[@pone.0164344.ref051]\]. Differential expression of the TPI and the PGM^BPI^ has not been detected across promastigote growth and differentiation of these visceral leishmaniasis-causative species in other studies. The enolase is down-regulated at the final stages of growth and differentiation of *L*. *amazonensis* (late-logarithmic phase) ([Fig 3](#pone.0164344.g003){ref-type="fig"}), which is analogous at the transcript level (over-expressed in metacyclics) in the case of *L*. *infantum* \[[@pone.0164344.ref033]\]. This protein is down-regulated in the amastigote stage of *L*. *mexicana*, *L*. *donovani* and *L*. *infantum* \[[@pone.0164344.ref021], [@pone.0164344.ref023], [@pone.0164344.ref024], [@pone.0164344.ref033]\]. The expression profile in *L*. *infantum* stationary phase metacyclic promastigotes is comparable at the transcript level \[[@pone.0164344.ref033]\].

![Differential abundance of proteins involved in *L*. *amazonensis* metabolism.\
Constitutively expressed and differentially regulated proteins that participate in glycolysis, the Krebs cycle, amino acid metabolism and β-oxidation of fatty acids are depicted. Colour legend for up-regulation: green, day 2 (lag/early log); blue, day 3 (log); orange, day 5 (late log); red, day 7 (stat). The constitutively expressed proteins experimentally detected throughout the promastigote growth curve are highlighted in violet. Abbreviations not detailed in the text: ALD, fructose-1,6-bisphosphate aldolase; ECH, enoyl-CoA hydratase/isomerase; FMR, fumarase; MET6, methyltetrahydropteroyltriglutamate-homocysteine methyltransferase; MDH, malate dehydrogenase; PGK, phosphoglycerate kinase; PK, pyruvate kinase; SDH, succinate dehydrogenase.](pone.0164344.g003){#pone.0164344.g003}

Three components of the pyruvate dehydrogenase complex (PDC), namely the E1β subunit, dihydrolipoamide dehydrogenase (DHLDH) and dihydrolipoamide acetyltransferase (DHLAT), are significantly up-regulated in early-logarithmic phase promastigotes ([Fig 3](#pone.0164344.g003){ref-type="fig"}, [Table 1](#pone.0164344.t001){ref-type="table"}). The aconitase is the only differentially abundant enzyme of the Krebs cycle found. This protein is over-expressed at the beginning of growth and differentiation of promastigotes (in early-logarithmic phase), like the PDC components mentioned above. On the opposite, the citrate synthase (CitS), isocitrate dehydrogenase (ICDH), succinyl-CoA synthetase α subunit (SCS) and GDP-forming succinyl-CoA ligase β chain (SCL) are constitutively expressed ([Fig 3](#pone.0164344.g003){ref-type="fig"}, [Table 2](#pone.0164344.t002){ref-type="table"}). The Rieske iron sulfur precursor (RISP) is a protein involved in the electron transport chain. RISP abundance decreases in late-logarithmic phase promastigotes, when growth and differentiation are at an advanced stage. Krebs cycle and iron-sulfur cluster-dependent enzymes have been associated to susceptibility to NO by growth inhibition depending on the redox state of sulfhydryl groups in pathogenic bacteria \[[@pone.0164344.ref052], [@pone.0164344.ref053]\].

In summary, the differentially abundant glycolytic enzymes TPI and enolase, the DHLDH and DHLAT components of the PDC and the electron transport chain protein RISP are down-regulated in the final stages of growth and differentiation of promastigotes, except for the increase of PGM^BPI^. These changes suggest higher demand of energy during the first stages of promastigote development and might be somehow associated to nitric oxide resistance, as proposed above. On the opposite, the acyl-CoA dehydrogenase, involved in β-oxidation of fatty acids, is up-regulated in stationary phase promastigotes ([Fig 3](#pone.0164344.g003){ref-type="fig"}, [Table 1](#pone.0164344.t001){ref-type="table"}), suggesting alternation in the energy source at this stage.

The GDP-mannose pyrophosphorylase (GDP-MP) is up-regulated in late-logarithmic phase promastigotes, which is in agreement with a previous observation in *L*. *infantum* promastigotes by the same approach \[[@pone.0164344.ref014]\]. The GDP-MP is essential for virulence of promastigotes of *L*. *mexicana* \[[@pone.0164344.ref054]\], a species closely related to *L*. *amazonensis*. This enzyme is involved in biosynthesis of the lipophosphoglycan (LPG), the glycosylinositol phospholipids (GIPLs) and other glycoconjugates characteristic of the surface of these parasites. The up-regulation of the GDP-MP in late-logarithmic phase promastigotes suggests that higher amounts of these surface molecules are synthesized when the end of growth and differentiation of promastigotes approaches.

Up-regulation of proteins involved in resistance and survival at the last stages of growth and development of *L*. *amazonensis* promastigotes {#sec016}
----------------------------------------------------------------------------------------------------------------------------------------------

### Trypanothione system {#sec017}

A processed protein variant (12.9 KDa, pI8.5) of the tryparedoxin peroxidase (TryP) is constitutively expressed throughout the growth curve of *L*. *amazonensis* promastigotes, whereas two heavier variants of estimated experimental MW and pI close to the theoretical values (22.0 KDa, pI6.0) are differentially abundant ([Fig 4](#pone.0164344.g004){ref-type="fig"}, Tables [1](#pone.0164344.t001){ref-type="table"} and [3](#pone.0164344.t003){ref-type="table"}). One of the TryP heavy variants is up-regulated at day 3, whereas the other one is down-regulated at the same time point. The TryP light variant is highly up-regulated (\>30-fold) in stationary phase promastigotes (day 7). In the case of *L*. *infantum*, the TryP decreases in amastigotes compared to promastigotes \[[@pone.0164344.ref028]\] but there are no available data about relative abundance during growth and differentiation process of amastigotes to date. The complex expression profiles of different TryP variants in *L*. *amazonensis* promastigotes ([Fig 4](#pone.0164344.g004){ref-type="fig"}) has not been found in Old World *Leishmania* species such as *L*. *major* or *L*. *infantum* so far and the enzyme was reported to be constitutively expressed in both species \[[@pone.0164344.ref020], [@pone.0164344.ref055]\], whereas the non-pathogenic trypanosomatid *C*. *fasciculata* differentially regulates the TryP across growth and differentiation of the motile choanomastigote stage \[[@pone.0164344.ref041]\]. In addition to cellular detoxification of reactive oxygen species, the TryP has been involved in other processes such signaling proliferation and differentiation \[[@pone.0164344.ref056]\]. The complex expression pattern of different variants found in *L*. *amazonensis* promastigotes ([Fig 4](#pone.0164344.g004){ref-type="fig"}) suggests that the TryP is especially important throughout the growth and differentiation process studied herein.

![Differential abundance of proteins involved in redox homeostasis.\
The FE-SOD participates in ROS processing providing hydrogen peroxide, which is then reduced by the TryP with the assistance of the TXN1, trypanithione and TryR. TryP differential expression pattern is complex through the promastigote growth curve of *L*. *amazonensis*. A light TryP variant is up-regulated in stationary phase promastigotes. A heavier TryP variant is down-regulated at day 3 and another one up-regulated simultaneously. Finally, a fourth variant is constitutively expressed during promastigote growth. Colour legend for up-regulation: green, day 2 (lag/early log); blue, day 3 (log); orange, day 5 (late log); red, day 7 (stat). The constitutively expressed proteins experimentally detected throughout the promastigote growth curve are highlighted in violet.](pone.0164344.g004){#pone.0164344.g004}

The iron superoxide dismutase (Fe-SOD) is over-expressed in *L*. *amazonensis* and in *C*. *fasciculata*. This protein initiates elimination of the superoxide anion by conversion to hydrogen peroxide. The Fe-SOD is up-regulated in *L*. *amazonensis* late logarithmic phase promastigotes (day 5). The TryP is able to reduce this substrate thanks to the assistance of the tryparedoxin (TXN1), the trypanothione (T\[S\]~2~/T\[SH\]~2~) and the NADPH-dependent enzyme trypanothione reductase (TryR). The TryR has not been identified between the selected spots of this analysis and the TXN1 is among the constitutively expressed ones ([Table 2](#pone.0164344.t002){ref-type="table"}).

### Arginase {#sec018}

The arginase is a manganese-dependent enzyme that participates in the urea cycle by hydrolyzing L-arginine into urea and ornithine. These products are able to induce the alternative macrophage activation pathway \[[@pone.0164344.ref057]\]. The ARG of the host phagocytic cell competes with the inducible nitric oxide synthase (iNOS) for the substrate L-arginine \[[@pone.0164344.ref058]\]. For these reasons, parasite clearance is more effective when low levels of host ARG are expressed. The ARG is also annotated in the genomes of the *Leishmania* species, thus contributing to decrease the levels of NO synthesis by the iNOS of the host cell through substrate competence. This enzyme is essential for infectivity, proliferation and virulence of the parasite \[[@pone.0164344.ref059], [@pone.0164344.ref060]\]. 2DE-MALDI-TOF/TOF analysis has revealed high ARG levels (29-fold) in *L*. *amazonensis* stationary phase promastigotes. *L*. *infantum* promastigotes overexpress the ARG in amastigotes with respect to stationary phase promastigotes \[[@pone.0164344.ref028]\]. A possible explanation for these findings combined is preparation in advance for differentiation to the amastigote stage and survival within the phagolysosome of the host cell. This statement is called pre-adaptation hypothesis and has been previously supported \[[@pone.0164344.ref020], [@pone.0164344.ref061]--[@pone.0164344.ref063]\]. The MTT test has confirmed that *L*. *amazonensis* stationary phase promastigotes are more resistant to NO than logarithmic phase promastigotes ([Fig 5](#pone.0164344.g005){ref-type="fig"}). Therefore, NO resistance increases in the ongoing of growth and development of promastigotes in culture.

![Resistance to NO of logarithmic and stationary phase promastigotes of *L*. *amazonensis*.\
The MTT assay was performed to compare the ability to resist increasing concentrations of NaNO~2~ by logarithmic and stationary phase promastigotes of *L*. *amazonensis*. Three biological replicates of the experiment were performed and the differences, contrasted by the paired t-test, were significant at all NaNO~2~ concentrations tested (p\*\<0.001).](pone.0164344.g005){#pone.0164344.g005}

Ornithine is an essential precursor in polyamine biosynthesis \[[@pone.0164344.ref054], [@pone.0164344.ref055]\]. This pathway is essential for the biosynthesis of trypanothione because this molecule consists of two glutathione residues coupled through spermidine. Consequently, arginase up-regulation might be indirectly related to the TryP differential expression profile found ([Fig 4](#pone.0164344.g004){ref-type="fig"}).

### Synopsis of differentially abundant proteins involved in survival and resistance {#sec019}

Decreased abundance of a variant of the STI1 chaperone simultaneous to the increase of the levels of the ARG, HSP70, TryP, Fe-SOD (stress-resistance proteins) and rPKA (indicative of differentiation) has been found when growth and differentiation of *L*. *amazonensis* promastigotes is complete. These changes, especially ARG up-regulation, may be linked to the increased ability of differentiated promastigotes to resist NO with respect to the non-differentiated, which is in agreement with the pre-adaptation hypothesis towards survival within the host phagocyte and may explain unsuccessful clearance by the immune system. In addition, higher levels of the GDP-ManP have been observed at an advanced growth phase, which probably leads to increased amounts of glycoconjugates in differentiated promastigotes.

Conclusions {#sec020}
===========

2DE-MS/MS has revealed that promastigotes of the New World species *L*. *amazonensis*, responsible for ACL, up-regulate proteins involved in survival and resistance throughout growth and development in culture: the TryP and the Fe-SOD, involved in defense against oxidative damage; the ARG, involved in nitrosative stress resistance within the phagocytic host cell, which is up-regulated in stationary phase promastigotes, thus supporting the pre-adaptative hypothesis; the immunostimulatory protein HSP 70, involved in protein folding; and the rPKA, involved in signaling and autophagy, thus related with metacyclogenesis. The LACK antigen is down-regulated throughout growth and simultaneous development of promastigotes in this species causative of ACL, whereas it was reported to be constitutively expressed in the VL agent *L*. *infantum*. The down-regulation of the STI1 and the up-regulation of proteins involved in resistance and survival (ARG, HSP70, Fe-SOD, TryP and rPKA) in fully grown and differentiated promastigotes suggest the pre-adaptative hypothesis, also proposed for other *Leishmania* species.
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###### Scatter plot of differential protein abundance in *L*. *amazonensis* promastigotes.
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Click here for additional data file.

###### Spot density values.
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